Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive TumorsHemic and Lymphatic Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, central nervous system cancer, digestive system neuroendocrine neoplasm, epithelial neoplasm, gastrointestinal stromal tumor, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myomatous neoplasm, neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcomaRecruitingPhase 12026-09-25NCT06441331

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
ITM Solucin GmbH3

7 results · Page 1 of 1

Swipe the table sideways for more columns.